◆英語タイトル:Kadimastem Ltd (KDST) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C15120
◆発行会社(調査会社):
GlobalData
◆発行日:2019年3月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イスラエル
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
※
販売価格オプションの説明はこちらで、
ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※
GlobalData社の概要はこちらでご確認いただけます。
【レポートの概要】
Summary
Kadimastem Ltd (Kadimastem) is a clinical stage biopharmaceutical company that develops industrial regenerative medicines to treat neuro-degenerative diseases. Its technology platform enables the manufacturing of islet-like endocrine cells (differentiated cells) and glia restricted progenitors derived from human pluripotent stem cells (hPSCs) thus having potential applications for diabetes, and for neurodegenerative diseases such as ALS. The company has developed a groundbreaking process to differentiate the cells in the lab, unlike other technologies which transplant immature precursor cells. Kadimastem’s regenerative medicine program is designed to allow large-scale production of encapsulated devices which is implanted in patients sensing blood glucose levels and secret insulin. The company provides drug discovery and development services. Kadimastem is headquartered in Ness Ziona, Israel.
Kadimastem Ltd Key Recent Developments
Nov 27,2018: Kadimastem to be included in the TASE Indices
Nov 12,2018: Kadimastem and Defymed Awarded Grant in the EU’s Prestigious Eurostars Program for the Clinical Development of an Integrated Product for the Treatment of Diabetes
Oct 09,2018: Medical Breakthrough on a Global Scale and Significant Achievement for Kadimastem
Jul 02,2018: Kadimastem and The Australian Foundation for Diabetes Research (AFDR) Selected to Receive a Bi-National Grant from the Australian Government and the Israel Innovation Authority to Explore a Combined Diabetes Solution
This comprehensive SWOT profile of Kadimastem Ltd provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Kadimastem Ltd including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).
The profile contains critical company information including*,
- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Note*: Some sections may be missing if data is unavailable for the company.
Key benefits of buying this profile include,
You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Table of Contents
Section 1 – About the Company
Kadimastem Ltd – Key Information
Kadimastem Ltd – Overview
Kadimastem Ltd – Key Employees
Kadimastem Ltd – Key Employee Biographies
Kadimastem Ltd – Key Operational Heads
Kadimastem Ltd – Major Products and Services
Kadimastem Ltd – History
Kadimastem Ltd – Company Statement
Kadimastem Ltd – Locations And Subsidiaries
Kadimastem Ltd – Key Manufacturing facilities
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Kadimastem Ltd – Business Description
Kadimastem Ltd – Corporate Strategy
Kadimastem Ltd – SWOT Analysis
SWOT Analysis – Overview
Kadimastem Ltd – Strengths
Kadimastem Ltd – Weaknesses
Kadimastem Ltd – Opportunities
Kadimastem Ltd – Threats
Kadimastem Ltd – Key Competitors
Section 3 – Company Financial Performance Charts
Kadimastem Ltd – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Appendix
Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
Note*: Some sections may be missing if data is unavailable for the company
List of Tables
Kadimastem Ltd, Key Information
Kadimastem Ltd, Key Ratios
Kadimastem Ltd, Share Data
Kadimastem Ltd, Major Products and Services
Kadimastem Ltd, History
Kadimastem Ltd, Key Employees
Kadimastem Ltd, Key Employee Biographies
Kadimastem Ltd, Key Operational Heads
Kadimastem Ltd, Other Locations
Kadimastem Ltd, Subsidiaries
Kadimastem Ltd, Key Manufacturing facilities
Kadimastem Ltd, Key Competitors
Kadimastem Ltd, SWOT Analysis
Kadimastem Ltd, Ratios based on current share price
Kadimastem Ltd, Annual Ratios
Kadimastem Ltd, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
List of Figures
Kadimastem Ltd, Performance Chart
Kadimastem Ltd, Ratio Charts